Almotriptan

Therapeutic indications

Almotriptan is indicated for:

Migraine attacks

Population group: both men and women, only adults (18 years old or older)

Almotriptan is indicated for the acute treatment of the headache phase of migraine attacks with or without aura.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Almotriptan is contraindicated in the following cases:

Ischaemic heart disease, hypertension

at least one of
Ischaemic heart diseases
High blood pressure

Lactation

Lactation

Ergotamine, ergotamine derivatives, 5-HT1B/1D agonists

at least one of
Ergot alkaloids
Ergot alkaloids
Ergot alkaloids
Ergot alkaloids
Selective serotonin (5HT1) agonists

Cerebrovascular accident (CVA) or transient ischaemic attack (TIA), peripheral vascular disease

at least one of
CVA - Cerebrovascular accident
TIA
Peripheral vascular disease

Severe hepatic disease

Hepatic failure stage IV

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2015: ALMOGRAN Film-coated tablet
< Previous: Overview
Next: Precautions >